Trademark Overview
On Thursday, April 9, 2026, a trademark application was filed for LUMINOS with the United States Patent and Trademark Office. The USPTO has given the LUMINOS trademark a serial number of 99753312. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, April 9, 2026. This trademark is owned by Discovery Life Sciences, LLC. The LUMINOS trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Scientific laboratory services in the field of genomics; Research and development services in the field of genomics; Research in the field of bioinformatics, namely, analysis and interpretation of genomic sequencing data; DNA sequencing technology research; Research in the field of DNA sequencing technology; Development of new technology for others in the field of genomics and molecular diagnostics; Scientific and technological services, namely, research and design in the field of next-generation sequencing and genomic data analysis; Scientific research in the nature of conducting clinical trials for others in the field of genomic medicine; Clinical laboratory testing services in the field of genomic profiling; Providing laboratory analysis services in the field of genomics, namely, analysis of nucleic acids derived from human biological samples; Genomic profiling services, namely, comprehensive next-generation sequencing of biological samples for use in clinical research and clinical ...
Medical research laboratory services in the field of genomic medicine; Medical analysis services in the field of genomic medicine, namely, genomic profiling and next-generation sequencing for clinical diagnostic and clinical research applications; Medical laboratory services, namely, genomic profiling and DNA sequencing services for use in clinical research and clinical trials; Providing genomic testing services for clinical research purposes, namely, comprehensive analysis of nucleic acids derived from human biological samples to support patient stratification, biomarker identification, and companion diagnostic development; Medical laboratory services, namely, clinical genomic testing and reporting services for use in the diagnosis and monitoring of human disease